Patents by Inventor Todd Marder

Todd Marder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fluorescent synthetic retinoids
    Patent number: 10759762
    Abstract: There are described novel compounds of formula I: which R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are each as herein defined.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: September 1, 2020
    Assignee: HIGH FORCE RESEARCH LIMITED
    Inventors: Andrew Whiting, Todd Marder
  • Fluorescent Synthetic Retinoids
    Publication number: 20170217893
    Abstract: There are described novel compounds of formula I: which R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are each as herein defined.
    Type: Application
    Filed: October 9, 2015
    Publication date: August 3, 2017
    Applicant: High Force Research Limited
    Inventors: Andrew Whiting, Todd Marder
  • Retinoid compounds and their use
    Patent number: 8293803
    Abstract: The invention relates to retinoid compounds of the formula (I): wherein V is a hydrophobic group; W is a non-polyenic linker; and X is a polar group comprising a hydrogen bond donor; or a salt thereof, and to the use of such compounds in the control of cell differentiation.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: October 23, 2012
    Assignee: Reinnervate Limited
    Inventors: Stefan Przyborski, Andrew Whiting, Todd Marder
  • RETINOID COMPOUNDS AND THEIR USE
    Publication number: 20100093088
    Abstract: The invention relates to retinoid compounds of the formula (I): wherein V is a hydrophobic group; W is a non-polyenic linker; and X is a polar group comprising a hydrogen bond donor; or a salt thereof, and to the use of such compounds in the control of cell differentiation.
    Type: Application
    Filed: August 28, 2007
    Publication date: April 15, 2010
    Applicant: REINNERVATE LIMITED
    Inventors: Stefan Przyborski, Andrew Whiting, Todd Marder